Verrica Pharmaceuticals

$13.76
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.19 (-1.36%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell VRCA and other stocks, options, and ETFs commission-free!

About VRCA

Verrica Pharmaceuticals, Inc. engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its lead product candidate VP-102, is a proprietary topical therapy used in common skin indications including molluscum contagiosum and verruca vulgaris.

CEO

Ted White

Employees

Headquarters

West Chester, Pennsylvania

Founded

2013

Market Cap

383.21M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

135.61K

High Today

$14.07

Low Today

$13.62

Open Price

$13.92

Volume

60.31K

52 Week High

$18.42

52 Week Low

$8.83

VRCA Earnings

-$0.52

-$0.35

-$0.17

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 4, Pre-Market